• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera ...
查看详情Guangzhou, China– June 2 , 2024 –Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical companydevel...
Bio-Theraand STADA have reached an exclusive commercialization and license agreement forBAT2506, a biosimilar candidate...
GUANGZHOU, China - Bio-Thera Solutions (688177.SH), a commercial-stage biopharmaceutical company developinginnovative th...
